Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Front Cardiovasc Med ; 8: 737505, 2021.
Article in English | MEDLINE | ID: mdl-34631835

ABSTRACT

There has been a huge increase in diabetes and its associated cardiovascular complications over the last decade, predominantly in the middle- and low-income countries. In these countries, the majority live in rural areas. The Rural Epidemiology of Diabetes in South India (REDSI) study was aimed to analyze the prevalence of diabetes, cardiovascular risk factors, and its complications in rural farming and non-farming villages in Tamil Nadu, South India. A research survey on the prevalence of self-reported diabetes, cardiovascular risk factors (age, sex, obesity, hypertension, hypercholesterolemia, alcohol and tobacco use) and agricultural occupational exposure was executed among 106,111 people from 61 villages in the state of Tamil Nadu, South India, during 2015-2018. Overall, we observed a diabetes prevalence of 11.9% in rural South India. A nearly two-fold higher prevalence of diabetes was observed among the farming community (15.0%) compared to that among the non-farming population (8.7%). Logistic regression analyses revealed a strong association with agrochemical exposure (P < 0.0001) and diabetes prevalence among rural farming people. Our survey indicates a high prevalence of diabetes in rural South India particularly among the farming community. This survey in conjunction with other epidemiological and experimental studies raises the need for understanding the etiology of diabetes and other cardiovascular risk factors in rural communities.

2.
Curr Diabetes Rev ; 16(8): 797-806, 2020.
Article in English | MEDLINE | ID: mdl-32000646

ABSTRACT

Diabetes mellitus is associated with an increased risk of micro and macrovascular complications. During hyperglycemic conditions, endothelial cells and vascular smooth muscle cells are exquisitely sensitive to high glucose. This high glucose-induced sustained reactive oxygen species production leads to redox imbalance, which is associated with endothelial dysfunction and vascular wall remodeling. Nrf2, a redox-regulated transcription factor plays a key role in the antioxidant response element (ARE)-mediated expression of antioxidant genes. Although accumulating data indicate the molecular mechanisms underpinning the Nrf2 regulated redox balance, understanding the influence of the Nrf2/ARE axis during hyperglycemic condition on vascular cells is paramount. This review focuses on the context-dependent role of Nrf2/ARE signaling on vascular endothelial and smooth muscle cell function during hyperglycemic conditions. This review also highlights improving the Nrf2 system in vascular tissues, which could be a potential therapeutic strategy for vascular dysfunction.


Subject(s)
Antioxidant Response Elements/genetics , Diabetes Mellitus, Type 2/genetics , Endothelial Cells/metabolism , Hyperglycemia/genetics , Myocytes, Smooth Muscle/metabolism , NF-E2-Related Factor 2/genetics , Animals , Antioxidant Response Elements/physiology , Antioxidants/metabolism , Diabetes Complications/genetics , Diabetes Complications/metabolism , Diabetes Complications/physiopathology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Diabetic Angiopathies/genetics , Diabetic Angiopathies/metabolism , Diabetic Angiopathies/physiopathology , Epigenesis, Genetic , Gene Expression Regulation/genetics , Gene Expression Regulation/physiology , Humans , Hyperglycemia/metabolism , Kelch-Like ECH-Associated Protein 1/genetics , Kelch-Like ECH-Associated Protein 1/metabolism , NF-E2-Related Factor 2/metabolism , Oxidation-Reduction , Oxidative Stress/genetics , Oxidative Stress/physiology , Phosphotransferases/genetics , Phosphotransferases/metabolism , Reactive Oxygen Species/adverse effects , Reactive Oxygen Species/metabolism , Signal Transduction/genetics , Signal Transduction/physiology
3.
Sci Rep ; 8(1): 17037, 2018 11 19.
Article in English | MEDLINE | ID: mdl-30451881

ABSTRACT

Caramel colours are the preferential food colouring agent globally, reaches wide age groups through eatables. Colas, a sweetened carbonated drink are most common caramel coloured beverage and its consumption is linked with diabetes, obesity, pancreatic cancer and other endocrine disorders. A major by-product produced during caramelization is 4-methylimidazole (4-MEI) that is detected in noteworthy concentrations in colas and other beverages. Previous studies revealed the neurotoxic and carcinogenic potential of 4-MEI in animals at higher doses but the effect of 4-MEI at theoretical maximum daily intake dose on glucose homeostasis is unexplored. Here, mice treated with 4-MEI (32 µg/kg bodyweight/day) for seven weeks exhibited severe hypoglycaemia and hyperinsulinemia mediated by hyperplasia of pancreatic beta cells and induces metabolic alterations. On combinatorial treatment, 4-MEI suppressed the glucogenic potential of non-artificial sweeteners and promotes lipogenesis. Furthermore, increased levels of C-peptide, LDL-cholesterol and triglycerides were observed in the humans with regular intake of 4-MEI containing beverages. In summary, 4-MEI induced pancreatic beta cell hyperplasia and leads to disruption of glucose and lipid homeostasis. This study suggests the need for further assessment and reconsideration of the wide usage of 4-MEI containing caramels as food additives.


Subject(s)
Blood Glucose/metabolism , Homeostasis/drug effects , Hyperinsulinism/chemically induced , Hypoglycemia/chemically induced , Imidazoles/administration & dosage , Imidazoles/toxicity , Insulin-Secreting Cells/metabolism , Animals , Apoptosis/drug effects , Female , Food Coloring Agents/administration & dosage , Food Coloring Agents/toxicity , Humans , Hyperplasia/pathology , Insulin/blood , Insulin-Secreting Cells/pathology , Lipid Metabolism/drug effects , Mice , Mice, Inbred BALB C , Oxidative Stress/drug effects
4.
Exp Cell Res ; 365(1): 46-56, 2018 04 01.
Article in English | MEDLINE | ID: mdl-29481791

ABSTRACT

The physiological cardiac hypertrophy is an adaptive condition without myocyte cell death, while pathological hypertrophy is a maladaptive condition associated with myocyte cell death. This study explores the miRNome of α-2M-induced physiologically hypertrophied cardiomyocytes and the role of miRNA-99 family during cardiac hypertrophy. Physiological and pathological cardiac hypertrophy was induced in H9c2 cardiomyoblast cell lines using α-2M and isoproterenol respectively. Total RNA isolation and small RNA sequencing were executed for physiological hypertrophy model. The differentially expressed miRNAs and its target mRNAs were validated in animal models. Transcription factor binding sites were predicted in the promoter of specific miRNAs and validated by ChIP-PCR. Subsequently, the selected miRNA was functionally characterized by overexpression and silencing. The effects of silencing of upstream regulator and downstream target gene were studied. Analysis of small RNA reads revealed the differential expression of a large set of miRNAs during hypertrophy, of which miR-99 family was highly downregulated upon α-2M treatment. However, this miR-99 family expression was upregulated during pathological hypertrophy and confirmed in animal models. ChIP-PCR confirms the binding of Egr-1 transcription factor to the miR-99 promoter. Further, silencing of Egr-1 decreased the expression of miR-99. The overexpression or silencing of miR-99 diverges the physiological hypertrophy to pathological hypertrophy and vice versa by regulating Akt-1 pathway. Silencing of Akt-1 replicates the effect of overexpression of miR-99. CONCLUSION: The results proved Egr-1 mediated regulation of miR-99 family that plays a key role in determining the fate of cardiac hypertrophy by regulating Akt-1 signaling.


Subject(s)
Cardiomegaly/genetics , Cardiomegaly/pathology , Early Growth Response Protein 1/genetics , MicroRNAs/genetics , Myocytes, Cardiac/pathology , Animals , Cell Line , Down-Regulation/genetics , Promoter Regions, Genetic/genetics , Rats , Rats, Wistar , Signal Transduction/genetics , Up-Regulation/genetics
5.
Genome Biol ; 18(1): 8, 2017 01 24.
Article in English | MEDLINE | ID: mdl-28115022

ABSTRACT

BACKGROUND: Organophosphates are the most frequently and largely applied insecticide in the world due to their biodegradable nature. Gut microbes were shown to degrade organophosphates and cause intestinal dysfunction. The diabetogenic nature of organophosphates was recently reported but the underlying molecular mechanism is unclear. We aimed to understand the role of gut microbiota in organophosphate-induced hyperglycemia and to unravel the molecular mechanism behind this process. RESULTS: Here we demonstrate a high prevalence of diabetes among people directly exposed to organophosphates in rural India (n = 3080). Correlation and linear regression analysis reveal a strong association between plasma organophosphate residues and HbA1c but no association with acetylcholine esterase was noticed. Chronic treatment of mice with organophosphate for 180 days confirms the induction of glucose intolerance with no significant change in acetylcholine esterase. Further fecal transplantation and culture transplantation experiments confirm the involvement of gut microbiota in organophosphate-induced glucose intolerance. Intestinal metatranscriptomic and host metabolomic analyses reveal that gut microbial organophosphate degradation produces short chain fatty acids like acetic acid, which induces gluconeogenesis and thereby accounts for glucose intolerance. Plasma organophosphate residues are positively correlated with fecal esterase activity and acetate level of human diabetes. CONCLUSION: Collectively, our results implicate gluconeogenesis as the key mechanism behind organophosphate-induced hyperglycemia, mediated by the organophosphate-degrading potential of gut microbiota. This study reveals the gut microbiome-mediated diabetogenic nature of organophosphates and hence that the usage of these insecticides should be reconsidered.


Subject(s)
Gastrointestinal Microbiome , Gluconeogenesis , Glucose Intolerance , Insecticides/metabolism , Organophosphates/metabolism , Acetic Acid/metabolism , Animals , Biomarkers , Blood Glucose , Diabetes Mellitus/etiology , Diabetes Mellitus/metabolism , Disease Models, Animal , Feces/chemistry , Feces/enzymology , Gluconeogenesis/drug effects , Glucose Intolerance/drug therapy , Glucose Tolerance Test , Humans , Hyperglycemia/blood , Hyperglycemia/etiology , Hyperglycemia/metabolism , Insecticides/toxicity , Mice , Organophosphates/toxicity , Oxidative Stress
SELECTION OF CITATIONS
SEARCH DETAIL
...